Methodology of isoproterenol-tilt table testing in patients with syncope
R Sheldon
and
S Killam
Cardiovascular Research Group, University of Calgary, Alberta, Canada.
To assess the impact of isoproterenol, duration of tilt, symptom development and hemodynamic changes on the outcome of tilt table tests, 100 patients with syncope underwent successive 80 degrees head-up tilt for 10 min during infusions of 0, 2 and 5 micrograms/min of isoproterenol. All 15 patients with another cause of syncope had a normal test result and 66 (78%) of the 85 patients with syncope of unknown origin had a test that resulted in syncope or presyncope. Isoproterenol was required to produce syncope or presyncope in greater than 90% of positive tests and 66% to 80% of positive tests required a dose of 5 micrograms/min of isoproterenol. Without isoproterenol, symptoms did not develop until after greater than or equal to 4 min of head-up tilt. With either 2 or 5 micrograms/min of isoproterenol, the half-time of symptom onset was 0.7 to 1.9 min and the rate of symptom development did not depend on the dose of isoproterenol. During syncope, the mean heart rate, systolic blood pressure and rate-pressure product each decreased significantly from 132 +/- 21 to 67 +/- 25 beats/min, 117 +/- 19 to 60 +/- 16 mm Hg and 15.3 +/- 2.9 to 4.2 +/- 2.2 x 10(3) mm Hg/min, respectively. During presyncope, mean trough rate-pressure product (5.5 +/- 2 x 10(3) mm Hg/min) was significantly higher (p = 0.027) than during syncope.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:

|
 |

|
 |
 
M. Brignole, J.-J. Blanc, R. Sutton, and A. Moya
CHAPTER 26 Syncope
ESC Textbook of Cardiovascular Medicine,
January 1, 2009;
2(1):
med-9780199566990-chapter - med-9780199566990-chapter.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. P. Vlahos, M. Tzoufi, C. S. Katsouras, T. Barka, I. Sionti, L. K. Michalis, A. Siamopoulou, and T. M. Kolettis
Provocation of Neurocardiogenic Syncope During Head-up Tilt Testing in Children: Comparison Between Isoproterenol and Nitroglycerin
Pediatrics,
February 1, 2007;
119(2):
e419 - e425.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Sheldon, S. Rose, S. Connolly, D. Ritchie, M.-L. Koshman, M. Frenneaux, and for the Syncope Symptom Study Investigators
Diagnostic criteria for vasovagal syncope based on a quantitative history
Eur. Heart J.,
February 1, 2006;
27(3):
344 - 350.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Béa. Brembilla-Perrot, I. Muhanna, M. Nippert, B. Popovic, D. Beurrier, P. Houriez, A. Terrier de la Chaise, O. Claudon, P. Louis, A. Abdelaal, et al.
Paradoxical effect of isoprenaline infusion
Europace,
January 1, 2005;
7(6):
621 - 627.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Guidelines on Management (diagnosis and treatment) of syncope - update 2004: The Task Force on Syncope, European Society of Cardiology
Europace,
January 1, 2004;
6(6):
467 - 537.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Sheldon, S. Rose, S. Connolly, and on behalf of the POST investigators
Prevention of Syncope Trial (POST): a randomized clinical trial of beta blockers in the prevention of vasovagal syncope: Rationale and study design
Europace,
January 1, 2003;
5(1):
71 - 75.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Sheldon, S. Rose, D. Ritchie, S. J. Connolly, M.-L. Koshman, M. A. Lee, M. Frenneaux, M. Fisher, and W. Murphy
Historical criteria that distinguish syncope from seizures
J. Am. Coll. Cardiol.,
July 3, 2002;
40(1):
142 - 148.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Task Force on Syncope, European Society of Cardiol, M Brignole, P Alboni, D Benditt, L Bergfeldt, J.J Blanc, P.E Bloch Thomsen, J.G van Dijk, A Fitzpatrick, S Hohnloser, et al.
Guidelines on management (diagnosis and treatment) of syncope
Eur. Heart J.,
August 1, 2001;
22(15):
1256 - 1306.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Lamarre-Cliche and J. Cusson
The fainting patient: value of the head-upright tilt-table test in adult patients with orthostatic intolerance
Can. Med. Assoc. J.,
February 1, 2001;
164(3):
372 - 376.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. C. Rowe, H. Calkins, K. DeBusk, R. McKenzie, R. Anand, G. Sharma, B. A. Cuccherini, N. Soto, P. Hohman, S. Snader, et al.
Fludrocortisone Acetate to Treat Neurally Mediated Hypotension in Chronic Fatigue Syndrome: A Randomized Controlled Trial
JAMA,
January 3, 2001;
285(1):
52 - 59.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Fenton, S. C. Hammill, R. F. Rea, P. A. Low, and W.-K. Shen
Vasovagal Syncope
Ann Intern Med,
November 7, 2000;
133(9):
714 - 725.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R A Kenny, D O'Shea, and S W Parry
The Newcastle protocols for head-up tilt table testing in the diagnosis of vasovagal syncope, carotid sinus hypersensitivity, and related disorders
Heart,
May 1, 2000;
83(5):
564 - 569.
[Full Text]
|
 |
|

|
 |

|
 |
 
A Zaidi, D Benitez, P A Gaydecki, A Vohra, and A P Fitzpatrick
Haemodynamic effects of increasing angle of head up tilt
Heart,
February 1, 2000;
83(2):
181 - 184.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
K.-C. Hung, F.-C. Lin, M.-S. Chern, H.-J. Chang, I.-C. Hsieh, and D. Wu
Mechanisms and clinical significance of transient atrioventricular block during dobutamine stress echocardiography
J. Am. Coll. Cardiol.,
October 1, 1999;
34(4):
998 - 1004.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W.-K. Shen, A. Jahangir, D. Beinborn, C. M. Lohse, D. O. Hodge, R. F. Rea, and S. C. Hammill
Utility of a single-stage isoproterenol tilt table test in adults: A randomized comparison with passive head-up tilt
J. Am. Coll. Cardiol.,
March 15, 1999;
33(4):
985 - 990.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kikushima, Y. Kobayashi, H. Nakagawa, and T. Katagiri
Triggering mechanism for neurally mediated syncope induced by head-up tilt test: Role of catecholamines and response to propranolol
J. Am. Coll. Cardiol.,
February 1, 1999;
33(2):
350 - 357.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Sagrista-Sauleda, B. Romero, G. Permanyer-Miralda, A. Moya, T. Rius-Gelabert, L. Mont Girbau, and J. Soler-Soler
Clinical usefulness of head-up tilt test in patients with syncope and intraventricular conduction defect
Europace,
January 1, 1999;
1(1):
63 - 68.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
K. E. Boehm, K. T. Kip, B. P. Grubb, and D. J. Kosinski
Neurocardiogenic Syncope: Response to Hormonal Therapy
Pediatrics,
April 1, 1997;
99(4):
623 - 623.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Sheldon, S. Rose, P. Flanagan, M. L. Koshman, and S. Killam
Risk Factors for Syncope Recurrence After a Positive Tilt-Table<$DOWNLINK> Test in Patients With Syncope
Circulation,
March 1, 1996;
93(5):
973 - 981.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
I. Bou-Holaigah, P. C. Rowe, J. Kan, and H. Calkins
The Relationship Between Neurally Mediated Hypotension and the Chronic Fatigue Syndrome
JAMA,
September 27, 1995;
274(12):
961 - 967.
[Abstract]
[PDF]
|
 |
|
|